Delivery Order SPE2DB22D1202-SPE2DB25FVJD8
- Not listed
- The Defense Logistics Agency awarded a $10,990.43 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Prevnar 20 vaccine in 0.5 milliliter syringes. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's established capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $4,901.31 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is being performed at the contractor's Conshohocken, Pennsylvania location. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $26,021.15 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccines in 0.5 mL syringe format on July 22, 2025, with ultimate completion scheduled for July 23, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of PREVNAR 20 vaccine in 0.5mL syringes, with a contract ceiling value of $10,730.40. This is a firm fixed-price delivery order with an ultimate completion date of August 6, 2025, and represents a non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical...
- On August 25, 2025, the Defense Logistics Agency awarded a delivery order valued at $126,623.96 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5 mL). This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $16,337.70 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Prevnar 20 syringes (0.5 mL). This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply services under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at the vendor's Conshohocken, Pennsylvania location, with an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) under a firm fixed-price contract valued at approximately $217K. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a direct procurement of this pneumococcal vaccine product for military and federal healthcare systems. This non-competitive delivery order is being performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Prevnar 20 syringes (0.5mL) with a ceiling value of $9,802.68. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is set to be completed by July 31, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $16,184.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 vaccine in 0.5mL syringes. This non-set-aside contract was awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) valued at $4,744.24 under a firm fixed price contract type. The award was made on August 12, 2025, with an ultimate completion date of August 13, 2025, and represents a non-competitive set-aside delivery against the company's larger Indefinite Delivery Contract with DLA. Performance of this delivery order will take place at AmerisourceBergen's facility in Conshohocken,...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVJD8Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,573.93 for PREVNAR 20 syringes (0.5mL) on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support military and federal healthcare requirements. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026. As a prime contractor to the Defense Logistics Agency's medical supply chain, AmerisourceBergen Drug Corp supplies a broad range of pharmaceutical products, vaccines, and medical supplies to support military healthcare systems worldwide, including the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. The company's contract portfolio demonstrates consistent competitively-awarded performance across multiple therapeutic domains and transaction values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 8/22/25 |